Publication Information

{'id': 'https://openalex.org/W2048832465', 'doi': 'https://doi.org/10.1097/00001756-199805110-00050', 'title': 'Tacrine and donepezil attenuate the neurotoxic effect of Aβ(25-35) in rat PC12 cells', 'display_name': 'Tacrine and donepezil attenuate the neurotoxic effect of Aβ(25-35) in rat PC12 cells', 'publication_year': 1998, 'publication_date': '1998-05-01', 'ids': {'openalex': 'https://openalex.org/W2048832465', 'doi': 'https://doi.org/10.1097/00001756-199805110-00050', 'mag': '2048832465', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/9631459'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/00001756-199805110-00050', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S121278948', 'display_name': 'Neuroreport', 'issn_l': '0959-4965', 'issn': ['0959-4965', '1473-558X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5108201747', 'display_name': 'Anne‐Lie Svensson', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I28166907', 'display_name': 'Karolinska Institutet', 'ror': 'https://ror.org/056d84691', 'country_code': 'SE', 'type': 'education', 'lineage': ['https://openalex.org/I28166907']}], 'countries': ['SE'], 'is_corresponding': False, 'raw_author_name': 'Anne-Lie Svensson', 'raw_affiliation_strings': ['Department of Clinical Neuroscience and Family Medicine, Division of Molecular Neuropharmacology, Karolinska Institute, Huddinge University Hospital B84, S-141 86 Huddinge, Sweden'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Neuroscience and Family Medicine, Division of Molecular Neuropharmacology, Karolinska Institute, Huddinge University Hospital B84, S-141 86 Huddinge, Sweden', 'institution_ids': ['https://openalex.org/I28166907']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5089411086', 'display_name': 'Agneta Nordberg', 'orcid': 'https://orcid.org/0000-0001-7345-5151'}, 'institutions': [{'id': 'https://openalex.org/I28166907', 'display_name': 'Karolinska Institutet', 'ror': 'https://ror.org/056d84691', 'country_code': 'SE', 'type': 'education', 'lineage': ['https://openalex.org/I28166907']}], 'countries': ['SE'], 'is_corresponding': False, 'raw_author_name': 'Agneta Nordberg', 'raw_affiliation_strings': ['Department of Clinical Neuroscience and Family Medicine, Division of Molecular Neuropharmacology, Karolinska Institute, Huddinge University Hospital B84, S-141 86 Huddinge, Sweden'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Neuroscience and Family Medicine, Division of Molecular Neuropharmacology, Karolinska Institute, Huddinge University Hospital B84, S-141 86 Huddinge, Sweden', 'institution_ids': ['https://openalex.org/I28166907']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 4.142, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 89, 'citation_normalized_percentile': {'value': 0.905031, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 95, 'max': 96}, 'biblio': {'volume': '9', 'issue': '7', 'first_page': '1519', 'last_page': '1522'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12023', 'display_name': 'Cholinesterase and Neurodegenerative Diseases', 'score': 0.9965, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12023', 'display_name': 'Cholinesterase and Neurodegenerative Diseases', 'score': 0.9965, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10077', 'display_name': 'Neuroscience and Neuropharmacology Research', 'score': 0.9961, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10086', 'display_name': "Alzheimer's disease research and treatments", 'score': 0.994, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/tacrine', 'display_name': 'Tacrine', 'score': 0.9801239}, {'id': 'https://openalex.org/keywords/neurotoxicity', 'display_name': 'Neurotoxicity', 'score': 0.5276973}], 'concepts': [{'id': 'https://openalex.org/C2779046751', 'wikidata': 'https://www.wikidata.org/wiki/Q421076', 'display_name': 'Tacrine', 'level': 4, 'score': 0.9801239}, {'id': 'https://openalex.org/C2780904820', 'wikidata': 'https://www.wikidata.org/wiki/Q415081', 'display_name': 'Donepezil', 'level': 4, 'score': 0.9034689}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.59368706}, {'id': 'https://openalex.org/C169760540', 'wikidata': 'https://www.wikidata.org/wiki/Q207011', 'display_name': 'Neuroscience', 'level': 1, 'score': 0.5390536}, {'id': 'https://openalex.org/C2779491297', 'wikidata': 'https://www.wikidata.org/wiki/Q3338704', 'display_name': 'Neurotoxicity', 'level': 3, 'score': 0.5276973}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.44006035}, {'id': 'https://openalex.org/C2778816929', 'wikidata': 'https://www.wikidata.org/wiki/Q22676679', 'display_name': 'Acetylcholinesterase', 'level': 3, 'score': 0.34915078}, {'id': 'https://openalex.org/C29730261', 'wikidata': 'https://www.wikidata.org/wiki/Q274160', 'display_name': 'Toxicity', 'level': 2, 'score': 0.32558212}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.3126526}, {'id': 'https://openalex.org/C15744967', 'wikidata': 'https://www.wikidata.org/wiki/Q9418', 'display_name': 'Psychology', 'level': 0, 'score': 0.31106523}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.26939785}, {'id': 'https://openalex.org/C2779483572', 'wikidata': 'https://www.wikidata.org/wiki/Q83030', 'display_name': 'Dementia', 'level': 3, 'score': 0.1881494}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.11491066}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.07849088}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D016229', 'descriptor_name': 'Amyloid beta-Peptides', 'qualifier_ui': 'Q000633', 'qualifier_name': 'toxicity', 'is_major_topic': True}, {'descriptor_ui': 'D002800', 'descriptor_name': 'Cholinesterase Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D007189', 'descriptor_name': 'Indans', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D009474', 'descriptor_name': 'Neurons', 'qualifier_ui': 'Q000166', 'qualifier_name': 'cytology', 'is_major_topic': True}, {'descriptor_ui': 'D018696', 'descriptor_name': 'Neuroprotective Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D009498', 'descriptor_name': 'Neurotoxins', 'qualifier_ui': 'Q000633', 'qualifier_name': 'toxicity', 'is_major_topic': True}, {'descriptor_ui': 'D016716', 'descriptor_name': 'PC12 Cells', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D010446', 'descriptor_name': 'Peptide Fragments', 'qualifier_ui': 'Q000633', 'qualifier_name': 'toxicity', 'is_major_topic': True}, {'descriptor_ui': 'D010880', 'descriptor_name': 'Piperidines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D013619', 'descriptor_name': 'Tacrine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000310', 'descriptor_name': 'Adrenal Gland Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016229', 'descriptor_name': 'Amyloid beta-Peptides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002470', 'descriptor_name': 'Cell Survival', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002470', 'descriptor_name': 'Cell Survival', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D002800', 'descriptor_name': 'Cholinesterase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077265', 'descriptor_name': 'Donepezil', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007189', 'descriptor_name': 'Indans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008464', 'descriptor_name': 'Mecamylamine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008464', 'descriptor_name': 'Mecamylamine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D009474', 'descriptor_name': 'Neurons', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009474', 'descriptor_name': 'Neurons', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D009498', 'descriptor_name': 'Neurotoxins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009498', 'descriptor_name': 'Neurotoxins', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D018733', 'descriptor_name': 'Nicotinic Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018733', 'descriptor_name': 'Nicotinic Antagonists', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D016716', 'descriptor_name': 'PC12 Cells', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016716', 'descriptor_name': 'PC12 Cells', 'qualifier_ui': 'Q000166', 'qualifier_name': 'cytology', 'is_major_topic': False}, {'descriptor_ui': 'D010446', 'descriptor_name': 'Peptide Fragments', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010673', 'descriptor_name': 'Pheochromocytoma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010880', 'descriptor_name': 'Piperidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051381', 'descriptor_name': 'Rats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013619', 'descriptor_name': 'Tacrine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014403', 'descriptor_name': 'Tubocurarine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014403', 'descriptor_name': 'Tubocurarine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/00001756-199805110-00050', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S121278948', 'display_name': 'Neuroreport', 'issn_l': '0959-4965', 'issn': ['0959-4965', '1473-558X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/9631459', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.68, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 13, 'referenced_works': ['https://openalex.org/W1818767073', 'https://openalex.org/W1967237003', 'https://openalex.org/W1970587959', 'https://openalex.org/W1985313555', 'https://openalex.org/W1994197596', 'https://openalex.org/W2028091371', 'https://openalex.org/W2054526986', 'https://openalex.org/W2059214757', 'https://openalex.org/W2082111607', 'https://openalex.org/W2086990101', 'https://openalex.org/W2091339547', 'https://openalex.org/W2174802300', 'https://openalex.org/W2402227851'], 'related_works': ['https://openalex.org/W4300703342', 'https://openalex.org/W2952093138', 'https://openalex.org/W242793321', 'https://openalex.org/W2411520618', 'https://openalex.org/W2383390938', 'https://openalex.org/W2377197747', 'https://openalex.org/W2069219578', 'https://openalex.org/W2051723148', 'https://openalex.org/W2034914545', 'https://openalex.org/W1967518376'], 'abstract_inverted_index': {'THE': [0], 'effect': [1, 45], 'of': [2, 46, 53, 84, 92, 98], 'the': [3, 21, 51, 54, 89, 96], 'cholinesterase': [4, 93], 'inhibitors': [5, 94], 'tacrine': [6, 47, 74], 'and': [7, 25, 60, 75, 86], 'donepezil': [8, 26, 76], 'on': [9], 'Aβ(25–35)-induced': [10, 38], 'toxicity': [11, 39], 'was': [12, 27, 48], 'investigated': [13], 'in': [14, 29, 40, 50, 95], 'rat': [15], 'pheochromocytoma': [16], 'PC12': [17, 41], 'cells': [18], 'by': [19], 'measuring': [20], 'mitochondrial': [22], 'activity.': [23], 'Tacrine': [24], 'found': [28], 'clinical': [30, 90], 'relevant': [31], 'concentrations': [32], '(10−7': [33], '−': [34], '10−6M)': [35], 'to': [36, 88], 'attenuate': [37], 'cells.': [42], 'The': [43], 'neuroprotective': [44, 79], 'blocked': [49], 'presence': [52], 'nicotinic': [55, 68], 'antagonists': [56], 'mecamylamine': [57], '(10−5': [58, 62], 'M)': [59], 'tubocurarine': [61], 'M),': [63], 'suggesting': [64], 'an': [65], 'interaction': [66], 'via': [67], 'receptors.': [69], 'This': [70], 'study': [71], 'demonstrates': [72], 'that': [73], 'can': [77], 'exert': [78], 'properties': [80], 'which': [81], 'might': [82], 'be': [83], 'importance': [85], 'contribute': [87], 'efficacy': [91], 'treatment': [97], "Alzheimer's": [99], 'disease.': [100]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2048832465', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 3}, {'year': 2016, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 3}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-12-07T19:46:59.794920', 'created_date': '2016-06-24'}